We are pleased to be featured as #SMEoftheWeek on Digital Health London Accelerator social channelspahini5Jul 28, 20221 min readThey highlight how Panakeia is changing the way biomarker testing is done through the use of #AI. Read more...
Panakeia to attend and present at upcoming scientific and business conferencesCambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...
Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium
Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancerPANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...
Comments